Norbert Suttorp to Prospective Studies
This is a "connection" page, showing publications Norbert Suttorp has written about Prospective Studies.
Connection Strength
0.050
-
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet Respir Med. 2021 11; 9(11):1255-1265.
Score: 0.010
-
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
Score: 0.010
-
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
Score: 0.009
-
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
Score: 0.009
-
Bronchial Injury After Atrial Fibrillation Ablation Using the Second-Generation Cryoballoon. Circ Arrhythm Electrophysiol. 2018 03; 11(3):e005925.
Score: 0.008
-
How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J. 2011 May; 37(5):1151-7.
Score: 0.005